Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons.

Saved in:
Bibliographic Details
Title: Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons.
Authors: Ison MG; Bethesda, Maryland, USA., Papi A; Pulmonary Division, University of Ferrara, St. Anna University Hospital, Ferrara, Italy., Athan E; Barwon Health, University Hospital Geelong, Geelong, Australia.; Centre for Innovation in Infectious Diseases and Immunology Research, Deakin University, Geelong, Australia., Feldman RG; Senior Clinical Trials, Inc, Laguna Hills, California, USA., Langley JM; Canadian Center for Vaccinology, Dalhousie University, IWK Health and Nova Scotia Health, Halifax, Canada., Lee DG; Division of Infectious Diseases, Department of Internal Medicine, Vaccine Bio Research Institute, College of Medicine, The Catholic University of Korea, Seoul, South Korea., Leroux-Roels I; Center for Vaccinology, Ghent University and Ghent University Hospital, Ghent, Belgium., Martinon-Torres F; Translational Pediatrics and Infectious Diseases, Pediatrics Department, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain.; Genetics, Vaccines, Infectious Diseases, and Pediatrics Research Group, Instituto de Investigación Sanitaria de Santiago, Universidad de Santiago de Compostela, Santiago de Compostela, Spain.; Consorcio Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain., Schwarz TF; Institute of Laboratory Medicine and Vaccination Center, Klinikum Würzburg Mitte, Campus Juliusspital, Würzburg, Germany., van Zyl-Smit RN; Division of Pulmonology and University of Cape Town Lung Institute, Department of Medicine, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa., Verheust C; GSK, Wavre, Belgium., Dezutter N; GSK, Wavre, Belgium., Gruselle O; GSK, Wavre, Belgium., Fissette L; GSK, Wavre, Belgium., David MP; GSK, Wavre, Belgium., Kostanyan L; GSK, Wavre, Belgium., Hulstrøm V; GSK, Wavre, Belgium., Olivier A; GSK, Wavre, Belgium., Van der Wielen M; GSK, Wavre, Belgium., Descamps D; GSK, Wavre, Belgium.
Corporate Authors: AReSVi-006 Study Group
Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Jun 14; Vol. 78 (6), pp. 1732-1744.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38253338
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ison+MG%22">Ison MG</searchLink>; Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Papi+A%22">Papi A</searchLink>; Pulmonary Division, University of Ferrara, St. Anna University Hospital, Ferrara, Italy.<br /><searchLink fieldCode="AU" term="%22Athan+E%22">Athan E</searchLink>; Barwon Health, University Hospital Geelong, Geelong, Australia.; Centre for Innovation in Infectious Diseases and Immunology Research, Deakin University, Geelong, Australia.<br /><searchLink fieldCode="AU" term="%22Feldman+RG%22">Feldman RG</searchLink>; Senior Clinical Trials, Inc, Laguna Hills, California, USA.<br /><searchLink fieldCode="AU" term="%22Langley+JM%22">Langley JM</searchLink>; Canadian Center for Vaccinology, Dalhousie University, IWK Health and Nova Scotia Health, Halifax, Canada.<br /><searchLink fieldCode="AU" term="%22Lee+DG%22">Lee DG</searchLink>; Division of Infectious Diseases, Department of Internal Medicine, Vaccine Bio Research Institute, College of Medicine, The Catholic University of Korea, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Leroux-Roels+I%22">Leroux-Roels I</searchLink>; Center for Vaccinology, Ghent University and Ghent University Hospital, Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22Martinon-Torres+F%22">Martinon-Torres F</searchLink>; Translational Pediatrics and Infectious Diseases, Pediatrics Department, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain.; Genetics, Vaccines, Infectious Diseases, and Pediatrics Research Group, Instituto de Investigación Sanitaria de Santiago, Universidad de Santiago de Compostela, Santiago de Compostela, Spain.; Consorcio Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Schwarz+TF%22">Schwarz TF</searchLink>; Institute of Laboratory Medicine and Vaccination Center, Klinikum Würzburg Mitte, Campus Juliusspital, Würzburg, Germany.<br /><searchLink fieldCode="AU" term="%22van+Zyl-Smit+RN%22">van Zyl-Smit RN</searchLink>; Division of Pulmonology and University of Cape Town Lung Institute, Department of Medicine, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Verheust+C%22">Verheust C</searchLink>; GSK, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22Dezutter+N%22">Dezutter N</searchLink>; GSK, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22Gruselle+O%22">Gruselle O</searchLink>; GSK, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22Fissette+L%22">Fissette L</searchLink>; GSK, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22David+MP%22">David MP</searchLink>; GSK, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22Kostanyan+L%22">Kostanyan L</searchLink>; GSK, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22Hulstrøm+V%22">Hulstrøm V</searchLink>; GSK, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22Olivier+A%22">Olivier A</searchLink>; GSK, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22Van+der+Wielen+M%22">Van der Wielen M</searchLink>; GSK, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22Descamps+D%22">Descamps D</searchLink>; GSK, Wavre, Belgium.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22AReSVi-006+Study+Group%22">AReSVi-006 Study Group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229203213%22">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</searchLink> [Clin Infect Dis] 2024 Jun 14; Vol. 78 (6), pp. 1732-1744.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9203213 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1537-6591 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210584838%22">10584838 </searchLink><i>NLM ISO Abbreviation: </i>Clin Infect Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38253338
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/cid/ciae010
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1732
    Titles:
      – TitleFull: Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ison MG
      – PersonEntity:
          Name:
            NameFull: Papi A
      – PersonEntity:
          Name:
            NameFull: Athan E
      – PersonEntity:
          Name:
            NameFull: Feldman RG
      – PersonEntity:
          Name:
            NameFull: Langley JM
      – PersonEntity:
          Name:
            NameFull: Lee DG
      – PersonEntity:
          Name:
            NameFull: Leroux-Roels I
      – PersonEntity:
          Name:
            NameFull: Martinon-Torres F
      – PersonEntity:
          Name:
            NameFull: Schwarz TF
      – PersonEntity:
          Name:
            NameFull: van Zyl-Smit RN
      – PersonEntity:
          Name:
            NameFull: Verheust C
      – PersonEntity:
          Name:
            NameFull: Dezutter N
      – PersonEntity:
          Name:
            NameFull: Gruselle O
      – PersonEntity:
          Name:
            NameFull: Fissette L
      – PersonEntity:
          Name:
            NameFull: David MP
      – PersonEntity:
          Name:
            NameFull: Kostanyan L
      – PersonEntity:
          Name:
            NameFull: Hulstrøm V
      – PersonEntity:
          Name:
            NameFull: Olivier A
      – PersonEntity:
          Name:
            NameFull: Van der Wielen M
      – PersonEntity:
          Name:
            NameFull: Descamps D
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 14
              M: 06
              Text: 2024 Jun 14
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1537-6591
          Numbering:
            – Type: volume
              Value: 78
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
              Type: main
ResultId 1